Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04343222 · ClinicalTrials.gov registry record · Phase 4
Control of Pain in Intravitreal Injections Using Topical NSAIDs
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT04343222 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 46 participants.
The verdict
NCT04343222, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
Intravitreal injections (IVI) are a common form of treatment for multiple retinal pathologies. The investigators hypothesize that an intervention with a topical NSAID will alleviate pain experienced at intravitreal injection (IVI) and post-IVI. 46 participants will be recruited, randomized into 1 of 3 treatment arms, and can expect to be on study for a day.
Interventions
- DRUG Artificial tears
- DRUG Bromfenac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2019-06-27 |
| Est. Completion | 2019-12-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04343222
The ClinicalTrials.gov registry entry for NCT04343222 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Artificial tears is the first listed.
NCT04343222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04343222 about?
NCT04343222 is a clinical study titled "Control of Pain in Intravitreal Injections Using Topical NSAIDs". Intravitreal injections (IVI) are a common form of treatment for multiple retinal pathologies. The investigators hypothesize that an intervention with a topical NSAID will alleviate pain experienced at intravitreal injection (IVI) and post-IVI. 46 participants will be recruited, randomized into 1 of...
What is the current status of trial NCT04343222?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2019-06-27. Estimated completion is 2019-12-19.
What interventions are being tested in trial NCT04343222?
The interventions under investigation include: Artificial tears (DRUG), Bromfenac (DRUG).
Who is sponsoring clinical trial NCT04343222?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.